Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (NUMI.TO)

Numinus Wellness Inc (NUMI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,439
  • Shares Outstanding, K 320,552
  • Annual Sales, $ 23,180 K
  • Annual Income, $ -30,256 K
  • 60-Month Beta 1.71
  • Price/Sales 0.80
  • Price/Cash Flow N/A
  • Price/Book 2.22
Trade NUMI.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.10
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +7.69%
on 05/17/24
0.0900 -22.22%
on 04/19/24
-0.0150 (-17.65%)
since 04/17/24
3-Month
0.0650 +7.69%
on 05/17/24
0.1250 -44.00%
on 03/07/24
-0.0500 (-41.67%)
since 02/16/24
52-Week
0.0650 +7.69%
on 05/17/24
0.2750 -74.55%
on 05/30/23
-0.0850 (-54.84%)
since 05/17/23

Most Recent Stories

More News
Stocks in play: Numinus Wellness Inc.

Announced a strategic plan designed to streamline expenses and sharpen the company's focus on its higher-growth ...

NUMI.TO : 0.0700 (unch)
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader in mental health care specializing in innovative and...

NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)
Stocks in play: Numinus Wellness Inc.

Announced that its research site, Cedar Clinical Research, has been chosen as one of multiple sites ...

NUMI.TO : 0.0700 (unch)
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)
Numinus Wellness Provides Corporate Update

Numinus sharpens its focus on streamlining operations and maximizing shareholder returns through a focus on U.S. operations and strategic adjustments in its...

NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

Q2 Fiscal 2024 Highlights Cash position of $6.6 million as of February 29, 2024 Gross profit of $0.5 million, a 22.7% decline over Q1 2024 Revenue of $5.0...

NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMI.TO : 0.0700 (unch)
NUMIF : 0.0513 (-5.18%)
Numinus Wellness Submits Clinical Trial Application

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)
Numinus Wellness Provides Corporate Update

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder

/CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative...

MNMD : 8.22 (-4.97%)
NUMIF : 0.0513 (-5.18%)
NUMI.TO : 0.0700 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted...

See More

Key Turning Points

3rd Resistance Point 0.0850
2nd Resistance Point 0.0800
1st Resistance Point 0.0750
Last Price 0.0700
1st Support Level 0.0650
2nd Support Level 0.0600
3rd Support Level 0.0550

See More

52-Week High 0.2750
Fibonacci 61.8% 0.1948
Fibonacci 50% 0.1700
Fibonacci 38.2% 0.1452
Last Price 0.0700
52-Week Low 0.0650

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar